Recall Register

Food, drugs, devices › Spacelabs Healthcare, Inc.

Device recall: Multi-parameter Command Module, Model 91496, optioned with Masimo or Nellcor

FDA enforcement event 98374 · Class II · initiated 27 Feb 2026 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordSnoqualmie, WA

Spacelabs Healthcare, Inc. (Snoqualmie, WA) initiated this device recall on 27 Feb 2026; FDA lists 1 product record under event 98374, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 572 device enforcement events initiated in 2026 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Spacelabs Healthcare, Inc. has 27 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Spacelabs Healthcare, Inc., Snoqualmie, WA.

Reason for recall

"Multi-parameter command module has a circuit board issue and when in Auto mode, Cardiac Output (CO) measurement may activate early, resulting in Bad Curve error with no CO measurement or Irregular Curve error with CO measurement not automatically excluded, which may result in inaccurate readings, or the need of additional readings, which may lead to delayed care and/or fluid overload."

Distribution

"Worldwide - US Nationwide distribution including in the states of NY, NJ, AL, OK, IA, MT, WY, MN, TX, WI, PA, WA, OR, MI, CA, SC, ID, FL, MS, KS, SD, LA, OH, MO, NH, GA, MD, TN, AZ, PR and the…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1793-2026Multi-parameter Command Module, Model 91496, optioned with Masimo or Nellcor1790Class IIOngoing15 Apr 2026

Context

87%of 2026 device events are Class II572 events that year
1product record in this eventfirm median: 1
27events on this register for the firm

Other enforcement events for Spacelabs Healthcare, Inc.

InitiatedProduct (first record)TypeClassRecords
4 Jun 2026Brand Name: Xhibit Product Name: Xhibit Central Station Model/Catalog Number: 96102 Software Version: N/A Product DescriDeviceClass II1
26 Mar 2026Brand Name: Spacelabs Ultraview SL Command Module Product Name: SL Command Module Model/Catalog Number: 91496 Software VDeviceClass II1
5 Sep 2025Brand Name: Branding is not applied to this product. Product Name: DVI display cables Model/Catalog Number: 012-0895-01 DeviceClass II3
25 Nov 2024Xhibit Telemetry Receiver with Software, Model 96280. Intended to provide monitoring system with patient data.DeviceClass II1
25 Nov 2024Xhibit Telemetry Receiver, Model 96280, with Service Manual. Intended to provide monitoring system with patient data.DeviceClass II1
12 Apr 2023Ultraview SL (UVSL) Command Module, Model 91496DeviceClass II1
31 May 2022Xhibit Telemetry Receiver, Model: 96280DeviceClass II1
30 Aug 2019Xhibit Central, Model No. 96102 - Product Usage: intended use is to provide clinicians with central monitoring of adult,DeviceClass II1
28 Jan 2019Spacelabs Healthcare Smart Disclosure System, Model 92810, a component of the Intesys Clinical Suite (ICS) G2.DeviceClass II1
17 Jan 2018Spacelabs Healthcare Xhibit Telemetry Receiver, Model 96280, software version 1.1, physiological patient monitor (with aDeviceClass II1

All 27 events for Spacelabs Healthcare, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Multi-parameter command module has a circuit board issue and when in Auto mode, Cardiac Output (CO) measurement may activate early, resulting in Bad Curve error with no CO measurement or Irregular Curve error with CO measurement not automatically excluded, which may result in inaccurate readings, or the need of additional readings, which may lead to delayed care and/or fluid overload."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide - US Nationwide distribution including in the states of NY, NJ, AL, OK, IA, MT, WY, MN, TX, WI, PA, WA, OR, MI, CA, SC, ID, FL, MS, KS, SD, LA, OH, MO, NH, GA, MD, TN, AZ, PR and the…"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.